Skip to main content
Fig. 1 | Global Health Research and Policy

Fig. 1

From: Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste

Fig. 1

Timor-Leste’s anti-TB drug resistance survey sample processing workflow. SS +  = sputum smear-positive (on microscopy); Prev Treated = previously treated; RIF = rifampicin; RR-TB = rifampicin-resistant TB (including MDR-TB); RS-TB = rifampicin-susceptible TB; pDST = phenotypic DST; WGS = whole genome sequencing; NTRL = National TB Reference Laboratory; SNRL = Supranational Laboratory

Back to article page